Back to Clinical Research

OHR-002

Status: Completed

ClinicalTrials.gov Identifier: NCT01678963

OHR-002: Ophthalmic drops (Squalamine Lactate) in patients with wet AMD.

Condition: Neovascular Age-Related Macular Degeneration

Study Type: Interventional

Duration: 29 months

Eligibility:

• Ages: 50 years and older
• Sexes: All
• Accepts Healthy Volunteers: No

For additional information on this study, please click here

Back to Clinical Research